Industry Overview

North America digital pathology market was valued at $531.5 million in 2025 and is projected to reach $3,492.3 million by 2035, growing at a CAGR of 20.8% during the forecast period (2026–2035). The North America digital pathology market is expanding as healthcare institutions increasingly adopt advanced imaging and diagnostic technologies to improve workflow efficiency and accuracy. Rising demand for remote diagnostics and teleconsultation is driving the integration of digital platforms in hospitals and reference laboratories. Pharmaceutical and biotechnology companies are leveraging digital pathology tools to accelerate drug discovery and streamline clinical research processes. Investment in AI-powered image analysis and cloud-based storage solutions is further supporting market growth. Regulatory encouragement for digital health initiatives and growing awareness of the benefits of digital pathology are contributing to sustained expansion across the region.

Market Dynamics

Rising Demand in Healthcare and Food Processing Industries

The North America digital pathology market is witnessing strong growth due to increasing demand from healthcare facilities and food processing units. Hospitals, laboratories, and clinics are adopting protective coatings to reduce infection risks and maintain hygienic surfaces. Similarly, the food and beverage sector is integrating anti-microbial layers to prevent microbial contamination and extend product safety. Regulatory authorities are emphasizing stricter hygiene standards, further encouraging adoption. Manufacturers are introducing solutions tailored to these industries, ensuring durability and effectiveness. This growing focus on safety and compliance is driving consistent market expansion.

Adoption of AI-Enabled Digital Pathology Platforms

The North America digital pathology market is witnessing rapid adoption of AI-enabled platforms that enhance diagnostic accuracy and workflow efficiency. Hospitals and research laboratories are increasingly integrating machine learning algorithms for tissue analysis, biomarker detection, and predictive diagnostics. Key players, including Leica Biosystems, Roche, and Philips, are developing AI-integrated solutions to streamline image interpretation and reduce turnaround times. The technology is also supporting pharmaceutical and biotechnology companies in accelerating drug discovery and clinical trials. Growing investment in computational pathology and AI validation studies is further driving adoption. This trend is expected to continue as digital pathology becomes a core component of modern healthcare infrastructure.

Expansion of Teleconsultation and Remote Diagnostics

Teleconsultation and remote diagnostic services are emerging as a significant growth driver in North America’s digital pathology market. Cloud-based platforms and secure image-sharing systems allow pathologists to provide consultations across hospitals and laboratories efficiently. The adoption of telepathology is particularly strong in regions facing specialist shortages or high patient volumes. Companies such as Sectra, Inspirata, and Proscia are offering solutions that integrate workflow management, AI analytics, and remote review capabilities. Increased regulatory support for digital health initiatives and rising acceptance of virtual diagnostics are further accelerating growth. This trend is strengthening the accessibility, efficiency, and reach of pathology services throughout the region.

Market Segmentation

• Based on the product, the market is segmented into scanner device, software and storage system.
• Based on the application, the market is segmented into teleconsultation, disease diagnosis, and drug discovery and other.
• Based on the end-user, the market is segmented into biotechnology & pharmaceutical companies, hospitals and others.

Scanner Devices Leading Product Segment Growth

Scanner devices have emerged as the largest and fastest-growing product sub-segment in North America’s digital pathology market. Growth is driven by increasing hospital adoption of high-throughput whole slide imaging systems and the need for accurate, reproducible diagnostics. Key players such as Leica Biosystems, Hamamatsu Photonics, and 3DHISTECH are introducing advanced scanners with automation, multiplex imaging, and integration with laboratory information systems. Recent trends include seamless compatibility with AI-powered software and enhanced workflow management tools. Expansion in both clinical diagnostics and pharmaceutical research is supporting steady market growth. Investments in digital infrastructure and demand for faster turnaround times continue to propel this sub-segment forward.

Drug Discovery Driving Rapid Growth in Digital Pathology Applications

Drug discovery has emerged as a rapidly growing application sub-segment in North America’s digital pathology market. Growth is driven by pharmaceutical and biotechnology companies leveraging digital pathology platforms for biomarker analysis, preclinical studies, and high-throughput tissue evaluation. Key players such as Roche, Proscia, and Visiopharm are providing AI-integrated software and workflow solutions to enhance efficiency and accuracy in research pipelines. Recent trends include the use of cloud-based storage and collaborative platforms to streamline multi-site studies and accelerate clinical trial timelines. Increasing investment in precision medicine and translational research is further boosting adoption. This sub-segment is expected to maintain strong growth as digital pathology becomes central to drug development workflows.

Regional Outlook

North America digital pathology market is further divided by countries, including US and Canada.

US Digital Pathology Market Expanding Through Clinical Integration

The US digital pathology market is witnessing strong growth as hospitals and diagnostic laboratories adopt advanced imaging and AI-powered analysis tools. Increasing demand for accurate and rapid diagnostics is driving integration of whole slide imaging scanners and software platforms into routine clinical workflows. Key players such as Leica Biosystems, Roche, and Philips are introducing solutions that enhance automation and efficiency. Trends include the growing use of teleconsultation networks to facilitate remote case reviews and collaborative diagnostics. Investment in cloud-based storage and workflow management systems is supporting scalability and data accessibility. These developments are reinforcing the adoption of digital pathology across major healthcare institutions in the US.

Market Players Outlook

The major companies operating in the North America digital pathology market include Akoya Biosciences, Inc., F. Hoffmann-La Roche Ltd. (Ventana), Leica Biosystems Nussloch GmbH, Philips N.V., and Proscia, Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In August 2025, PathAI and Moffitt Cancer Center announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight Dx, across Moffitt’s pathology programs to transform cancer detection and innovation. AISight Dx, is PathAI’s cloud-native digital pathology image management system designed to support both laboratory workflow and translational research use cases.

• In July 2025, Pramana received Health Canada authorisation for its digital pathology scanners, SpectralM and SpectralHT Cubiq. The regulatory approval allows the AI-enabled health tech company to import, market, and sell its devices in Canada, expanding its reach in the digital pathology sector. The focus on advanced imaging and workflow solutions aims to modernise diagnostic processes in Canadian medical facilities.

• In March 2025, Aiforia Technologies announced a partnership with Quorum Technologies. This collaboration aims to accelerate the adoption of Aiforia’s AI-assisted image analysis solutions across Canada. By combining their collective expertise, the companies aim to enhance scientific discoveries and patient care through improved accuracy and increased workflow efficiency in digital pathology image analysis.

• In July 2024, AGFA HealthCare announced that Enterprise Imaging for Pathology, powered by Corista DP3, is now available in North America. This specialty solution is built for Pathologists by Pathologists and healthcare software experts, enabling Pathologists to work comfortably in their familiar flow.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the North America digital pathology market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.